Eli Lilly and Company (LLY): What the Financials Tell Us

Eli Lilly and Company (NYSE:LLY) saw an upside of 0.33% to close Friday at $233.94 after adding $0.76 on the day. The 5-day average trading volume is 2,922,840 shares of the company’s common stock. It has gained $235.81 in the past week. An average of 2,945,880 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,683,094.

LLY’s 1-month performance is -2.53% or -$20.90 on its low of $220.20 reached on 09/28/21. The company’s shares have touched a 52-week low of $129.21 and high of $275.87, with the stock’s rally to the 52-week high happening on 08/17/21. YTD, LLY has achieved 38.56% or $65.10. However, the current price is down -15.20%% from the 52-week high price.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Insider Transactions

On Aug 18, 54 days have gone by since the last insider trading activity for Eli Lilly and Company (LLY). LILLY ENDOWMENT INC (10% Owner) most recently sold 15,430 shares at $274.31 per share on Aug 18. This transaction cost the insider $4,232,603. 10% Owner, LILLY ENDOWMENT INC, sold 3,060 shares at a price of $274.08 on Aug 17. Then, on Aug 09, 10% Owner LILLY ENDOWMENT INC sold 104,711 shares at a price of $267.50 per share. This transaction amounted to $28,010,135.

Valuation Metrics

The company’s PE ratio for the last five years has touched a high of 263.64 and a low of 13.06. LLY stock has a beta of 0.28. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 8.35 while the price-to-book (PB) in the most recent quarter is 32.95, with the price to cash flow ratio at 83.21.

Eli Lilly and Company pays an annual dividend of $3.40 per share. Its dividend yield is 1.45% and the payout ratio is 47.60%. LLY’s most recent quarterly dividend payment was made on Sep. 10, when it paid $0.85 a share compared with prior rate of $0.85, down 0.0% from last year’s. The company has boosted its dividend for the last 7 consecutive years with the latest dividend increase of $0.11 reported on Monday December 14 2020. Measured over the last 3 years, the Dividend has been growing by 42.31% yearly.

It is projected that Eli Lilly and Company’s next ex-dividend date will be on 15-Nov. LLY is expected to distribute $0.85 as its next dividend.

Eli Lilly and Company’s quick ratio for the period ended June 29 was 0.90, with the current ratio over the same period at 1.10 meaning that LLY stock is not able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 2.29, while the total debt to equity was 2.56. In terms of profitability, the gross margin trailing 12 months is 74.30%. The trailing 12-month EBITDA margin is 33.31% while for the period ending June 29; Eli Lilly and Company’s operating margin was 21.80%. The firm’s gross profit as reported stood at $19.06 billion against revenue of $24.54 billion.

Earnings Surprise

For the quarterly period ending June 29 this year, Eli Lilly and Company’s cash and short-term investments amounted to $51.2 million against total debt of $16.6 billion. Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected LLY to announce $1.63 per share in earnings in its latest quarter, but it posted $1.61, representing a -1.20% surprise. EBITDA for the quarter stood at more than $1.77 billion. LLY stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 41.15 billion, with total debt at $16.6 billion. Shareholders hold equity totaling $956.58 million

Technical Picture

Let’s look briefly at Eli Lilly and Company (LLY) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 October was 52.52% to suggest the stock is trending Neutral, with historical volatility in this time period at 32.33%.

The stock’s 5-day moving average is $230.15, reflecting a +1.89% or $4.35 change from its current price. LLY is currently trading -2.32% above its 20-day SMA, +20.20% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -4.64% and +40.32% respectively.

Stochastic %K and %D was 67.55% and 57.80% and the average true range (ATR) pointed at 5.86. The RSI (14) points at 47.64%, while the 14-day stochastic is at 81.01% with the period’s ATR at 5.80. The stock’s 9-day MACD Oscillator is pointing at 2.40 and 2.22 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Eli Lilly and Company (NYSE: LLY), Citigroup upgraded it to a Buy rating. They previously had a Neutral rating on the stock. Analysts offering their rating for LLY stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate LLY as a “sell,”, while 6 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 2 rates the stock as overweight while 9 have offered a “buy” rating.

What is LLY’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $230.00 and a high of $315.00, with their median price target at $279.00. Looking at these predictions, the average price target given by analysts is for Eli Lilly and Company (LLY) stock is $274.47.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img

Hot Topics

Related Videos

Related Videos

Related Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

592

100% free. stop anytime no spam